Registration OPEN!
Friday 19th November 11am - 2pm
The 2021 NCCRED Symposium will bring into focus three key areas of concern and innovation related to emerging drugs – Interventions, Networks & Pharmacotherapies. The symposium hosts leading national clinical researchers in the AoD field including presentations from recipients of NCCRED’s Round 3 Seed Funding Grants and the current work of the Centre. Areas of exploration in the 2021 symposium include:
- Interventions to assist early treatment and improved outcomes for methamphetamine dependence
- Pharmacotherapy trials for the treatment of methamphetamine dependence
- Developments in drug alerts and national communication networks
Register now, its free
Guest International Presenter
Dr. Madhukar Trivedi
Madhukar Trivedi, M.D., is a Professor of Psychiatry, Chief of the Division of Mood Disorders, and founding Director of the Center for Depression Research and Clinical Care at UT Southwestern Medical Center, where he holds the Betty Ho Hay Distinguished Chair in Mental Health and the Julie K. Hersh Chair for Depression Research and Clinical Care. Certified by the American Board of Psychiatry and Neurology, Dr. Trivedi focuses on developing and validating biosignatures of depression. He also conducts research on pharmacological, psychosocial, and nonpharmacological treatments for depression. He has been a principal investigator on numerous translational research projects and clinical trials.
For More information including the full program visit our website
The National Centre for Clinical Research on Emerging Drugs is made up of a consortium of the following four institutions
|
|
